GlassScriptPhysician profile
Cheryl Stomberg
NPI 1003500661
$529.86
in general payments reported to CMS, 2019-2025
7 companies · $458 in 2025
The $458 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $72.20 · 2025: $458.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446 · Education: $83.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $445.87 |
| Education | $83.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $125.00 | 2025 | |
| Amgen INC. | $121.88 | 2025 | Imdelltra (Amg757) |
| Janssen Biotech, INC. | $120.95 | 2024-2025 | Tecvayli, Darzalex, Talvey |
| Legend Biotech USA INC. | $55.22 | 2024-2025 | Carvykti |
| Kite Pharma, INC. | $42.56 | 2025 | Yescarta |
| Janssen Scientific Affairs, LLC | $40.15 | 2025 | Carvykti, Darzalex, Talvey |
| Adaptimmune LLC | $24.10 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Stomberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.